MADCAM1 and neoplasm: Previously, we have shown that gastric cancer patients have a decreased expression of MAdCAM-1 on tumor blood vessels, and that this was accompanied by fewer α4β7+ LPL in tumor mucosa compared to unaffected mucosa [17].